Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev made this statement in his column for the Newsweek magazine
More than 50 countries have submitted requests to Russia for procuring the Russian-made anti-coronavirus drug Avifavir.
Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev made this statement in his column for the Newsweek magazine, reports TASS.
Russia's neighbours Belarus and Kazakhstan have already bought the drug, he said.
Besides, more than 50 countries including Colombia, Brazil, Bulgaria, Mexico, Saudi Arabia, and Peru have submitted purchase requests, said Dmitriev.
The production of Avifavir has been increased to 300,000 courses a month, to supply both local and international demand, added the official.
So far, over 13 million confirmed COVID-19 cases have been reported globally, with over 570,000 fatalities and more than 7.2 million recoveries as of Tuesday, according to the latest tally from Johns Hopkins University.
Coronavirus cases were first reported in China in December last year.